Skip to main content
Signal8

Cavers Greg

SEC insider (Form 3/4/5 filer). CIK 0002116548. Chief Financial Officer at Helus Pharma Inc. (HELP). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 29, 2026. Located in TORONTO.

Companies Cavers Greg has filed insider reports for

  • Helus Pharma Inc. (HELP): Officer, Chief Financial Officer
Cavers Greg profile photo

Cavers Greg

CIK: 0002116548

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Helus Pharma Inc. logo
HELP

Helus Pharma Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Helus Pharma Inc. logo
    HELP

    Helus Pharma Inc.

    Sep 29, 2026
    Purchase
    Indirect
    3K shares at avg. $12.91$39K

1-1 of 1